Elsevier

Pathology

Volume 39, Issue 3, June 2007, Pages 349-353
Pathology

Clinical utility of serum soluble transferrin receptor levels and comparison with bone marrow iron stores as an index for iron-deficient erythropoiesis in a heterogeneous group of patients

https://doi.org/10.1080/00313020701329732Get rights and content

Summary

Aim

To evaluate the correlation between raised soluble transferrin receptor (sTfR) and stainable marrow iron, and to define the utility of sTfR in discriminating between the presence or absence of iron-deficient erythropoiesis in patients with anaemia of chronic disease.

Methods

Seventy-six consecutive adult patients without accelerated erythropoiesis who had undergone bone marrow (BM) aspiration/trephine for various clinical reasons during 2003-2006 were studied. All patients had serum iron studies (iron, transferrin and ferritin) and sTfR performed within 1 week of BM aspiration/trephine. These 76 patients were assigned to three groups based on the iron status of the BM and sTfR level: patients with normal sTfR and normal BM iron stores (n = 49), patients with an elevated sTfR and normal BM iron stores (n = 13) and patients reduced or absent BM iron stores (n = 14). Means (95% confidence interval) for mean corpuscular volume (MCV), mean corpuscular haemoglobin concentration (MCHC), red blood cell haemoglobin (RBC Hb) content and median (5th and 95th percentiles) for haemoglobin were then calculated.

Results

All patients with absent BM iron stores had an elevated sTfR level. Patients with normal BM iron stores and elevated sTfR levels had significantly lower Hb, MCV, MCHC and RBC Hb content than patients with normal BM iron stores and normal sTfR levels.

Conclusion

sTfR is the most sensitive serum biochemical marker for the identification of iron-deficient erythropoiesis. Normal BM iron stores can coexist with elevated sTfR and decreased MCV and MCHC. sTfR levels correlate better than BM iron stores with decreased MCV and MCHC. Therefore, sTfR is a useful marker of iron-deficient erythropoiesis, due to both absent iron stores, and restricted iron supply due to anaemia of chronic disease. As a single investigation, however, sTfR does not discriminate between these two causes of iron-deficient erythropoiesis.

References (22)

  • BeguinY.

    Soluble transferrin receptor for the evaluation of erythropoiesis and iron status

    Clin Chim Acta

    (2003)
  • KohgoY. et al.

    Serum transferrin receptor as a new index of erythropoiesis

    Blood

    (1987)
  • HuebersH.A. et al.

    Intact transferrin receptors in human plasma and their relation to erythropoiesis

    Blood

    (1990)
  • NicolasG. et al.

    Severe iron deficiency anemia in transgenic mice expressing liver hepcidin

    Proc Natl Acad Sci USA

    (2002)
  • NemethE. et al.

    IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin

    J Clin Invest

    (2004)
  • RoyC.N. et al.

    Anemia of inflammation: the hepcidin link

    Curr Opin Hematol

    (2005)
  • HuebersH.A. et al.

    The physiology of transferrin and transferrin receptors

    Physiol Rev

    (1987)
  • FergusonB.J. et al.

    Serum transferrin receptor distinguishes the anemia of chronic disease from iron deficiency anemia

    J Lab Clin Med

    (1992)
  • SuominenP. et al.

    Single values of serum transferrin receptor and transferrin receptor ferritin index can be used to detect true and functional iron deficiency in rheumatoid arthritis patients with anemia

    Arthritis Rheum

    (2000)
  • MargeticS. et al.

    Soluble transferrin receptor and transferrin receptor-ferritin index in iron deficiency anemia and anemia in rheumatoid arthritis

    Clin Chem Lab Med

    (2005)
  • MastA.E. et al.

    Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations

    Clin Chem

    (1998)
  • Cited by (0)

    View full text